These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27344717)

  • 1. [Molecules associated with invasion and metastasis in prostate cancer].
    Ashida S; Inoue K; Shuin T
    Nihon Rinsho; 2016 May; 74 Suppl 3():135-9. PubMed ID: 27344717
    [No Abstract]   [Full Text] [Related]  

  • 2. Epithelial plasticity in prostate cancer: principles and clinical perspectives.
    Das R; Gregory PA; Hollier BG; Tilley WD; Selth LA
    Trends Mol Med; 2014 Nov; 20(11):643-51. PubMed ID: 25262538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of prostate cancer invasion and metastasis].
    Sakamoto S; Ichikawa T
    Nihon Rinsho; 2014 Dec; 72(12):2086-9. PubMed ID: 25518338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells.
    Huo C; Kao YH; Chuu CP
    Cancer Lett; 2015 Dec; 369(1):103-11. PubMed ID: 26297988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of invasion and metastasis of prostate cancer: over view].
    Kanayama H
    Nihon Rinsho; 2016 May; 74 Suppl 3():129-34. PubMed ID: 27344716
    [No Abstract]   [Full Text] [Related]  

  • 6. [Molecular and anatomical mechanism of bone metastasis in prostate cancer].
    Yokomizo A; Shiota M
    Nihon Rinsho; 2016 May; 74 Suppl 3():145-8. PubMed ID: 27344719
    [No Abstract]   [Full Text] [Related]  

  • 7. Androgen receptor: good guy or bad guy in prostate cancer invasion?
    Baldi E; Bonaccorsi L; Forti G
    Endocrinology; 2003 May; 144(5):1653-5. PubMed ID: 12697667
    [No Abstract]   [Full Text] [Related]  

  • 8. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
    Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
    Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.
    Sun Y; Wang BE; Leong KG; Yue P; Li L; Jhunjhunwala S; Chen D; Seo K; Modrusan Z; Gao WQ; Settleman J; Johnson L
    Cancer Res; 2012 Jan; 72(2):527-36. PubMed ID: 22108827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanisms of leupaxin involved in prostate carcinoma metastasis].
    Zhu GH; Dai HP; Shen Q
    Zhonghua Nan Ke Xue; 2013 Jun; 19(6):555-8. PubMed ID: 23862238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microRNA code for prostate cancer metastasis.
    Bonci D; Coppola V; Patrizii M; Addario A; Cannistraci A; Francescangeli F; Pecci R; Muto G; Collura D; Bedini R; Zeuner A; Valtieri M; Sentinelli S; Benassi MS; Gallucci M; Carlini P; Piccolo S; De Maria R
    Oncogene; 2016 Mar; 35(9):1180-92. PubMed ID: 26073083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor and invasion in prostate cancer.
    Hara T; Miyazaki H; Lee A; Tran CP; Reiter RE
    Cancer Res; 2008 Feb; 68(4):1128-35. PubMed ID: 18281488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
    Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
    Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals.
    Luo J; Lee SO; Cui Y; Yang R; Li L; Chang C
    Oncotarget; 2015 Sep; 6(29):27555-65. PubMed ID: 26342197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of tumor cell plasticity by the androgen receptor in prostate cancer.
    Bishop JL; Davies A; Ketola K; Zoubeidi A
    Endocr Relat Cancer; 2015 Jun; 22(3):R165-82. PubMed ID: 25934687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of metastasis: prostate cancer.
    Glaves D
    Prog Clin Biol Res; 1987; 239():329-45. PubMed ID: 3309960
    [No Abstract]   [Full Text] [Related]  

  • 20. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
    Xu S; Zhang Z; Ogawa O; Yoshikawa T; Sakamoto H; Shibasaki N; Goto T; Wang L; Terada N
    Cell Biochem Biophys; 2014 Sep; 70(1):521-7. PubMed ID: 24744183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.